BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$2.66
-0.35 (-11.63%)
▼
5d:
-13.36%
30d:
-17.9%
90d:
+288.89%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jun 26, 2026
1d
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BDRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BDRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $2.66, which is considered oversold relative to its 30-day fair value range of $3.00 to $3.39.
Technical Outlook: Technically, BDRX is in a strong uptrend. Immediate support is located at $2.45, while resistance sits at $3.30. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: BDRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $35.10 (+1219.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDRX is in a strong uptrend. Immediate support is located at $2.45, while resistance sits at $3.30. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: BDRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $35.10 (+1219.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.00 -
$3.39
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.6%)
- BULLISH: Trading 1219.5% below Wall St target ($35.10)
- CAUTION: 5-day price weakness (-13.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$3.00 -
$3.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.45
Resistance Level
$3.30
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Wall Street Target
$35.10
(+1219.5%)
Revenue Growth (YoY)
-64.1%
Share & Embed Analysis
Last updated: June 23, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
